NORTH AMERICA RESPIRATORY TRAINER MARKET ANALYSIS

North America Respiratory Trainer MarketSize and Trends

The North America respiratory trainer market is estimated to be valued at US$ 190.2 Million in 2021 and expected to exhibit a CAGR of 7.3% during the forecast period (2021-2028).

Figure 1. North America Respiratory Trainer Market Share (%) in Terms of Value, by Product Type, 2021

Increasing prevalence of respiratory disorders is expected to drive the North America respiratory trainer market growth over the forecast period.

The rising incidence of respiratory disorders is expected to drive the North America respiratory trainer market growth over the forecast period. For instance, according to the Asthma and Allergy Foundation of America in 2021, 25 million Americans have asthma each year. This equals to about 1 in 13 Americans, including 8% adults and 7% children, and about 20 million U.S. adults aged 18 years and older have asthma.

Market Trends: Increasing development and launches of novel respiratory trainer devices is expected to drive the market growth during the forecast period.

Key market players are focusing on the development and launch of novel respiratory trainer devices in order to expand their product portfolio and presence in the market. For instance, in August 2021, IngMar Medical, the world leader in breathing simulation, announced the launch of RespiPro, IngMar Medical's next-generation breathing and ventilation training solution. The solution includes a realistic breathing simulator, the ASL 5000, plus user-friendly software, realistic patient monitors, and a compact intensive care unit breathing mannequin.